Category: pharmacological
Aliases: Nucynta
Centrally-acting μ-opioid agonist + norepinephrine reuptake inhibitor — dual mechanism gives analgesic effect with lower opioid receptor occupancy than equipotent morphine, reducing GI side effects. Schedule II. CYP-independent metabolism (UGT2B7) limits DDI footprint.
PO: 4h